Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
226,664,950
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
2,668,374
-
Shares change
-
-38,168
-
Total reported value, excl. options
-
$13,262,947
-
Value change
-
+$159,629
-
Number of buys
-
12
-
Number of sells
-
32
-
Price
-
$4.97
Institutional Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) as of Q2 2021
As of 30 Jun 2021 Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (RENB) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,668,374 shares of stock of the company.
Largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Virtu Financial LLC, TRUIST FINANCIAL CORP, Ergoteles LLC, and UNITED CAPITAL FINANCIAL ADVISERS, LLC.
This table shows 31 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.